Successful control of a hospital-wide outbreak of OXA-48 producing enterobacteriaceae in the Netherlands, 2009 to 2011

Eurosurveillance

Volumn 19, Issue 9, 2014, Pages

  Dautzenberg, M J ^a,b   Ossewaarde, J M ^a   de Kraker, M E ^c   van der Zee, A ^a   van Burgh, S ^a   de Greeff, S C ^c   Bijlmer, H A ^c   Grundmann, H ^c,d   Cohen Stuart, J W ^b   Fluit, A C ^b   Troelstra, A ^b   Bonten, M J ^b  

^a Maasstad Hospital Rotterdam   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^d UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

IMIPENEM; MEROPENEM;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ADHERENCE; DISEASE TRANSMISSION; ENTEROBACTERIACEAE; ENTEROBACTERIACEAE OXA 48; FEMALE; HUMAN; INFECTION CONTROL; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MIDDLE AGED; MINIMUM INHIBITORY CONCENTRATION; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; RETROSPECTIVE STUDY;

ADULT; AGED; AMPLIFIED FRAGMENT LENGTH POLYMORPHISM ANALYSIS; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; CROSS INFECTION; DISEASE OUTBREAKS; ENTEROBACTERIACEAE INFECTIONS; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; INFECTION CONTROL; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MULTILOCUS SEQUENCE TYPING; NETHERLANDS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PLASMIDS; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES;

EID: 84896820857     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.9.20723     Document Type: Article

References (32)

1. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011;53(1):60-7. http://dx.doi.org/10.1093/cid/cir202
2. Nordmann P, Naas T, Poirel L. Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2011;17(10):1791-8. http://dx.doi.org/10.3201/eid1710.110655
3. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008;8(3):159-66. http://dx.doi.org/10.1016/S1473-3099(08)70041-0
4. Poirel L, Héritier C, Tolün V, Nordmann P. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2004;48(1):15-22. http://dx.doi.org/10.1128/AAC.48.1.15-22.2004
5. Nagano N, Endoh Y, Nagano Y, Toyama M, Matsui M, Shibayama K, et al. First report of OXA-48 carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in Japan from a patient returned from Southeast Asia. Jpn J Infect Dis. 2013;66(1):79-81. http://dx.doi.org/10.7883/yoken.66.79
6. Ktari S, Mnif B, Louati F, Rekik S, Mezghani S, Mahjoubi F et al. Spread of Klebsiella pneumoniae isolates producing OXA-48 beta-lactamase in a Tunisian university hospital. J Antimicrob Chemother. 2011;66(7):1644-6. http://dx.doi.org/10.1093/jac/dkr181
7. Moquet O, Bouchiat C, Kinana A, Seck A, Arouna O, Bercion R et al. Class D OXA-48 carbapenemase in multidrug-resistant enterobacteria, Senegal. Emerg Infect Dis. 2011;17(1):143-4. http://dx.doi.org/10.3201/eid1701.100244
8. Poirel L, Ros A, Carrer A, Fortineau N, Carricajo A, Berthelot P et al. Cross-border transmission of OXA-48-producing Enterobacter cloacae from Morocco to France. J Antimicrob Chemother. 2011;66(5):1181-2. http://dx.doi.org/10.1093/jac/dkr023
9. Brink AJ, Coetzee J, Corcoran C, Clay CG, Hari-Makkan D, Jacobson RK, et al. Emergence of OXA-48 and OXA-181 carbapenemases among Enterobacteriaceae in South Africa and evidence of in vivo selection of colistin resistance as a consequence of selective decontamination of the gastrointestinal tract. J Clin Microbiol. 2013;51(1):369-72. http://dx.doi.org/10.1128/JCM.02234-12
10. Cuzon G, Ouanich J, Gondret R, Naas T, Nordmann P. Outbreak of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in France. Antimicrob Agents Chemother. 2011;55(5):2420-3. http://dx.doi.org/10.1128/AAC.01452-10
11. Glupczynski Y, Huang TD, Bouchahrouf W, Rezende de Castro R, Bauraing C, Gérard M et al. Rapid emergence and spread of OXA-48-producing carbapenem-resistant Enterobacteriaceae isolates in Belgian hospitals. Int J Antimicrob Agents. 2012;39(2):168-72. http://dx.doi.org/10.1016/j.ijantimicag.2011.10.005
12. Pitart C, Solé M, Roca I, Fàbrega A, Vila J, Marco F. First outbreak of a plasmid-mediated carbapenem-hydrolyzing OXA-48 beta-lactamase in Klebsiella pneumoniae in Spain. Antimicrob Agents Chemother. 2011;55(9):4398-401. http://dx.doi.org/10.1128/AAC.00329-11
13. Lascols C, Peirano G, Hackel M, Laupland KB, Pitout JD. Surveillance and molecular epidemiology of Klebsiella pneumoniae isolates that produce carbapenemases: first report of OXA-48-like enzymes in North America. Antimicrob Agents Chemother. 2013;57(1):130-6. http://dx.doi.org/10.1128/AAC.01686-12
14. Carrër A, Poirel L, Eraksoy H, Cagatay AA, Badur S, Nordmann P. Spread of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae isolates in Istanbul, Turkey. Antimicrob Agents Chemother. 2008;52(8):2950-4. http://dx.doi.org/10.1128/AAC.01672-07
15. Carrër A, Poirel L, Yilmaz M, Akan OA, Feriha C, Cuzon G et al. Spread of OXA-48-encoding plasmid in Turkey and beyond. Antimicrob Agents Chemother. 2010;54(3):1369-73. http://dx.doi.org/10.1128/AAC.01312-09
16. Crémet L, Bourigault C, Lepelletier D, Guillouzouic A, Juvin ME, Reynaud A et al. Nosocomial outbreak of carbapenem-resistant Enterobacter cloacae highlighting the interspecies transferability of the blaOXA-48 gene in the gut flora. J Antimicrob Chemother. 2012;67(4):1041-3. http://dx.doi.org/10.1093/jac/dkr547
17. Levast M, Poirel L, Carrër A, Deiber M, Decroisette E, Mallaval FO et al. Transfer of OXA-48-positive carbapenem-resistant Klebsiella pneumoniae from Turkey to France. J Antimicrob Chemother. 2011;66(4):944-5. http://dx.doi.org/10.1093/jac/dkq504
18. Dutch Working party on Infection Prevention. Measures to prevent the transmission of highly resistant microorganisms (HRMO). 2005. [Accessed 17 Aug 2012]. Available from:http://www.wip.nl/UK/free_content/Richtlijnen/HRMO.pdf
19. Poirel L, Walsh TR, Cuvillier V, Nordmann P. Multiplex PCR for detection of acquired carbapenemase genes. Diagn Microbiol Infect Dis. 2011;70(1):119-23. http://dx.doi.org/10.1016/j.diagmicrobio.2010.12.002
20. Nerderlandse Vereniging voor Medische Microbiologie (NVMM). Guideline Laboratory detection of highly resistant microorganisms, version 1.0. 2011. Leeuwarden:NVMM; 2011. [Accessed 5 Mar 2014]. Available from:http://www.med-info.nl/Richtlijnen/Infectieziekten/Laboratory%20detection%20of%20highly%20resistant%20microorganisms%20(HRMO).pdf
21. Van der Zee A, Steer N, Thijssen E, Nelson J, van't Veen A, Buiting A. Use of multienzyme multiplex PCR amplified fragment length polymorphism typing in analysis of outbreaks of multiresistant Klebsiella pneumoniae in an intensive care unit. J Clin Microbiol. 2003;41(2):798-802. http://dx.doi.org/10.1128/JCM.41.2.798-802.2003
22. Donnarumma F, Indorato C, Mastromei G, Goti E, Nicoletti P, Pecile P, et al. Molecular analysis of population structure and antibiotic resistance of Klebsiella isolates from a three-year surveillance program in Florence hospitals, Italy. Eur J Clin Microbiol Infect Dis. 2012;31(3):371-8. http://dx.doi.org/10.1007/s10096-011-1319-6
23. Clinical and Laboratory Standards Institute (CSLI). Performance Standards for Antimicrobial Susceptibility Testing; Twentieth Informational Supplement (June 2010 Update). Wayne, PA: CSLI; 2010. CLSI document M100-S20-U.
24. Clinical and Laboratory Standards Institute (CSLI). Performance Standards for Antimicrobial Susceptibility Testing; Sixteenth Informational Supplement. Wayne, PA: CSLI; 2006. CLSI document M100-S16.
25. Cohen Stuart J, Voets G, Rottier W, Voskuil S, Scharringa J, Van Dijk K, et al. Evaluation of the Oxoid Brilliance™ CRE Agar for the detection of carbapenemase-producing Enterobacteriaceae. Eur J Clin Microbiol Infect Dis. 2013;32(11):1445-9. http://dx.doi.org/10.1007/s10096-013-1896-7
26. Nordmann P, Poirel L, Dortet L. Rapid detection of carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis. 2012;18(9):1503-7. http://dx.doi.org/10.3201/eid1809.120355
27. Saidel-Odes L, Polachek H, Peled N, Riesenberg K, Schlaeffer F, Trabelsi Y et al. A randomized, double-blind, placebo-controlled trial of selective digestive decontamination using oral gentamicin and oral polymyxin E for eradication of carbapenem-resistant Klebsiella pneumoniae carriage. Infect Control Hosp Epidemiol. 2012;33(1):14-9. http://dx.doi.org/10.1086/663206
28. Brun-Buisson C, Legrand P, Rauss A, Richard C, Montravers F, Besbes M et al. Intestinal decontamination for control of nosocomial multiresistant gram-negative bacilli. Study of an outbreak in an intensive care unit. Ann Intern Med. 1989;110(11):873-81. http://dx.doi.org/10.7326/0003-4819-110-11-873
29. Oostdijk EA, de Smet AM, Kesecioglu J, Bonten MJ. Decontamination of cephalosporin-resistant Enterobacteriaceae during selective digestive tract decontamination in intensive care units. J Antimicrob Chemother. 2012;67(9):2250-3. http://dx.doi.org/10.1093/jac/dks187
30. de Smet AM, Kluytmans JA, Cooper BS, Mascini EM, Benus RF, van der Werf TS, et al. Decontamination of the digestive tract and oropharynx in ICU patients. N Engl J Med. 2009;360(1):20-31. http://dx.doi.org/10.1056/NEJMoa0800394
31. Pa-o-Pardo JR, Ruiz-Carrascoso G, Navarro-San Francisco C, Gómez-Gil R, Mora-Rillo M, Romero-Gómez MP, et al. Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak. J Antimicrob Chemother. 2013;68(1):89-96. http://dx.doi.org/10.1093/jac/dks364
32. Huang TD, Berhin C, Bogaerts P, Glupczynski Y; multicentre study group. Prevalence and mechanisms of resistance to carbapenems in Enterobacteriaceae isolates from 24 hospitals in Belgium. J Antimicrob Chemother. 2013;68(8):1832-7. http://dx.doi.org/10.1093/jac/dkt096